Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,267 | 4 | 68.6% |
| Food and Beverage | $580.38 | 16 | 31.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ethicon Inc. | $1,319 | 6 | $0 (2022) |
| Inspire Medical Systems, Inc. | $144.31 | 1 | $0 (2024) |
| Grifols USA, LLC | $78.22 | 1 | $0 (2017) |
| Merck Sharp & Dohme LLC | $73.83 | 5 | $0 (2022) |
| Jazz Pharmaceuticals Inc. | $61.94 | 1 | $0 (2018) |
| Mylan Specialty L.P. | $57.07 | 1 | $0 (2023) |
| CSL Behring | $28.92 | 1 | $0 (2023) |
| GENZYME CORPORATION | $24.42 | 1 | $0 (2023) |
| GlaxoSmithKline, LLC. | $23.93 | 1 | $0 (2017) |
| Paratek Pharmaceuticals, Inc. | $22.25 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $144.31 | 1 | Inspire Medical Systems, Inc. ($144.31) |
| 2023 | $132.66 | 4 | Mylan Specialty L.P. ($57.07) |
| 2022 | $1,339 | 7 | Ethicon Inc. ($1,319) |
| 2018 | $61.94 | 1 | Jazz Pharmaceuticals Inc. ($61.94) |
| 2017 | $169.50 | 7 | Grifols USA, LLC ($78.22) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $144.31 | General |
| Category: NEUROLOGY | ||||||
| 08/13/2023 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $57.07 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 04/28/2023 | CSL Behring | Kcentra (Biological) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: Trauma (Emergency, Injury, Surgery) | ||||||
| 03/29/2023 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.42 | General |
| Category: Immunology | ||||||
| 01/17/2023 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: ANTIBIOTIC | ||||||
| 06/09/2022 | Ethicon Inc. | Monarch Platform (Device) | Travel and Lodging | In-kind items and services | $111.09 | General |
| Category: Endo-Mechanical | ||||||
| 06/04/2022 | Ethicon Inc. | Monarch Platform (Device) | Travel and Lodging | In-kind items and services | $143.11 | General |
| Category: Endo-Mechanical | ||||||
| 06/03/2022 | Ethicon Inc. | Monarch Platform (Device) | Travel and Lodging | In-kind items and services | $133.82 | General |
| Category: Endo-Mechanical | ||||||
| 06/02/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $30.68 | General |
| Category: Endo-Mechanical | ||||||
| 06/02/2022 | Ethicon Inc. | Monarch Platform (Device) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Endo-Mechanical | ||||||
| 06/01/2022 | Merck Sharp & Dohme LLC | GARDASIL 9 (Biological), PNEUMOVAX 23, VAXNEUVANCE | Food and Beverage | In-kind items and services | $19.64 | General |
| Category: VACCINE | ||||||
| 05/27/2022 | Ethicon Inc. | Monarch Platform (Device) | Travel and Lodging | In-kind items and services | $878.79 | General |
| Category: Endo-Mechanical | ||||||
| 10/02/2018 | Jazz Pharmaceuticals Inc. | Xyrem (Drug) | Food and Beverage | In-kind items and services | $61.94 | General |
| Category: Neurology | ||||||
| 11/17/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: ENDOCRINOLOGY | ||||||
| 11/03/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: ENDOCRINOLOGY | ||||||
| 07/14/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $18.84 | General |
| Category: ENDOCRINOLOGY | ||||||
| 05/30/2017 | Grifols USA, LLC | Prolastin-C (Biological) | Food and Beverage | In-kind items and services | $78.22 | General |
| Category: Pulmonology | ||||||
| 05/30/2017 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $23.93 | General |
| Category: RESPIRATORY | ||||||
| 02/17/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, PNEUMOVAX 23 | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/24/2017 | Bayer HealthCare Pharmaceuticals Inc. | Adempas (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: Cardio-pulmonary | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 664 | 779 | $122,174 | $39,567 |
| 2022 | 10 | 640 | 753 | $92,852 | $35,685 |
| 2021 | 10 | 497 | 600 | $95,989 | $34,837 |
| 2020 | 8 | 485 | 731 | $221,591 | $62,967 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 111 | $75,111 | $18,176 | 24.2% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 54 | 86 | $15,853 | $7,913 | 49.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 37 | 37 | $10,101 | $4,879 | 48.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 18 | $3,798 | $2,392 | 63.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 14 | 16 | $2,416 | $1,478 | 61.2% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2023 | 180 | 183 | $2,196 | $1,147 | 52.2% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2023 | 164 | 168 | $2,184 | $1,141 | 52.2% |
| 31624 | Irrigation and suction of lung airways to obtain cells using an endoscope | Facility | 2023 | 13 | 13 | $7,854 | $1,132 | 14.4% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2023 | 116 | 120 | $2,040 | $1,097 | 53.8% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2023 | 26 | 27 | $621.00 | $213.03 | 34.3% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 26 | 75 | $50,763 | $12,779 | 25.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 39 | 92 | $14,233 | $7,327 | 51.5% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 34 | $9,282 | $5,236 | 56.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 15 | 18 | $3,798 | $2,451 | 64.5% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 15 | 15 | $4,125 | $2,206 | 53.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 18 | 20 | $3,020 | $1,981 | 65.6% |
| 94729 | Test to examine how well the lungs exchange gases | Facility | 2022 | 170 | 171 | $2,565 | $1,197 | 46.7% |
| 94010 | Test to measure expiratory airflow and volume | Facility | 2022 | 183 | 184 | $2,480 | $1,181 | 47.6% |
| 94726 | Test to determine lung volumes using sensors | Facility | 2022 | 120 | 121 | $2,057 | $1,140 | 55.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Facility | 2022 | 23 | 23 | $529.00 | $186.72 | 35.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 41 | 89 | $59,725 | $15,455 | 25.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 54 | 104 | $16,897 | $8,332 | 49.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 31 | 31 | $8,463 | $4,909 | 58.0% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 14 | 14 | $3,850 | $2,202 | 57.2% |
| 99443 | Physician telephone patient service, 21-30 minutes of medical discussion | Office | 2021 | 12 | 14 | $1,974 | $1,241 | 62.9% |
About Dr. Alberto Monegro, M.D
Dr. Alberto Monegro, M.D is a Critical Care Medicine healthcare provider based in Buffalo, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/03/2012. The National Provider Identifier (NPI) number assigned to this provider is 1073872552.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Alberto Monegro, M.D has received a total of $1,847 in payments from pharmaceutical and medical device companies, with $144.31 received in 2024. These payments were reported across 20 transactions from 11 companies. The most common payment nature is "Travel and Lodging" ($1,267).
As a Medicare-enrolled provider, Monegro has provided services to 2,286 Medicare beneficiaries, totaling 2,863 services with total Medicare billing of $173,057. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Internal Medicine
- Location Buffalo, NY
- Active Since 05/03/2012
- Last Updated 10/14/2022
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1073872552
Products in Payments
- Monarch Platform (Device) $1,319
- INSPIRE (Device) $144.31
- Prolastin-C (Biological) $78.22
- Xyrem (Drug) $61.94
- YUPELRI (Drug) $57.07
- JANUVIA (Drug) $54.19
- Kcentra (Biological) $28.92
- DUPIXENT (Biological) $24.42
- NUCALA (Biological) $23.93
- NUZYRA (Drug) $22.25
- GARDASIL 9 (Biological) $19.64
- Adempas (Drug) $13.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Buffalo
Dr. Nashat Rabadi, Md, MD
Critical Care Medicine — Payments: $599,049
Dr. Francois Fadell, M.d, M.D
Critical Care Medicine — Payments: $4,467
Kumar Shah, Md, MD
Critical Care Medicine — Payments: $2,553
Ann Steinwald, Np, NP
Critical Care Medicine — Payments: $1,495
Jessica Miller, Pa-C, PA-C
Critical Care Medicine — Payments: $1,328
Lucy Campbell, Md, MD
Critical Care Medicine — Payments: $195.92